MedTrace Logo

Magnetic Resonance Imaging and Spectroscopy at High Field

NCT00611013 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-06-21

No results posted yet for this study

Summary

Evaluating novel MR imaging techniques on volunteers.

Conditions

  • Healthy

Interventions

DEVICE

Magnetic Resonance Imaging

Some participants may receive MRI contrast agent, 0.1 mmol/kg

Sponsors & Collaborators

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Lutfi T Muftuler, Ph.D. · University of California, Irvine

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00611013 on ClinicalTrials.gov